Braskem (BAK) Gains from Investment Securities (2009 - 2025)

Braskem (BAK) posted quarterly Gains from Investment Securities of $373.7 million for Q1 2025, up 3304.65% on a QoQ basis from $11.0 million in Q4 2018.

Braskem (BAK) Gains from Investment Securities (2009 - 2025) Analysis & Trends

Braskem (BAK) has reported Gains from Investment Securities for 3 consecutive years, with $373.7 million the latest figure, recorded in Q1 2025.

  • Quarterly Gains from Investment Securities changed N/A year-over-year to $373.7 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $427.1 million (changed N/A YoY) and the FY2018 annual result came in at $12.9 million, changed N/A from the prior year.
  • Gains from Investment Securities improved to $373.7 million in Q1 2025 per BAK's latest filing, from $11.0 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for BAK reached as high as $373.7 million in Q1 2025 and fell as low as $373.7 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Celanese 4.87 Bn 3.11 Bn 468.00 Mn
2 Methanex 4.17 Bn 3.79 Bn -
3 Olin 2.49 Bn 2.30 Bn 75.80 Mn
4 Braskem 1.94 Bn -258.84 Mn -
5 Rex American Resources 1.46 Bn 1.09 Bn 28.91 Mn
6 Green Plains 1.14 Bn 956.17 Mn 87.95 Mn
7 Tronox Holdings 943.01 Mn 931.01 Mn 44.00 Mn
8 Lsb Industries 830.33 Mn 648.69 Mn 35.79 Mn
9 Westlake Chemical Partners 773.29 Mn 729.00 Mn 93.76 Mn
10 Rayonier Advanced Materials 573.66 Mn 505.71 Mn -7.59 Mn

Historic Data

Download Data
DateValue
Mar 31, 2025 373.74 Mn
Mar 31, 2025 373.74 Mn
Dec 31, 2018 10.98 Mn
Dec 31, 2018 10.98 Mn
Dec 31, 2009 13,254.81
Dec 31, 2009 13,254.81